Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL
Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL is recorded as a service provider in 1 clinical trial. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 1 of 1 trials · Latest update first
Phase II, randomized, open-label, international, multicenter study to compare efficacy of standard chemotherapy vs. letrozole plus abemaciclib as neoadjuvant therapy in HR-positive/HER2-negative high/intermediate risk breast cancer patients “CARABELA Study”
Sponsor Fundacion Grupo Espanol De Investigacion En Cancer De Mama
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL?
The 2026-10-09 snapshot links Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL to 1 distinct CTIS trials. Recorded services include Generation of PDX mouse models from fresh tumor samples.. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL conducted?
The linked trials record locations in 1 country, including Spain. These are trial locations, not confirmed office locations or countries where Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL delivered services.
What can this page tell me about Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL's trial experience?
Browse 1 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Fundacio Institut D'Investigacio Biomedica De Bellvitge IDIBELL